Professor, Assoc. Dean for Clinical Research, Emory University School of Medicine
Infectious Disease
Dr. Jeffrey L. Lennox, MD
|
|
Give Review
Dr. Jeffrey L. Lennox works in the field of Infectious Disease. He went to medical school at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a one of the best medicals schools. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. Jeffrey Lennox is a published doctor. He has 71 papers published. The most current publication "Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients." He accepts all Medicare patients.
Publications
- Comparison of the Metabolic Effects of Ritonavir boosted Darunavir or Atazanavir versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Executive Summary: Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association ...
- Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection.
- Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages.
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious D...
- Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.
- Metabolomics of Bronchoalveolar Lavage Differentiate Healthy HIV-1-Infected Subjects from Controls.
- Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
- Durable Efficacy and Safety of Raltegravir versus Efavirenz When Combined With Tenofovir/Emtricitabine In Treatment-Naive HIV-1 Infected Patients: Final Five-Year Resu...
- Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T cell activation.
- The use of HIV-1 integrase inhibitors in antiretroviral naive patients.
- Female Genital Tract Shedding of CXCR4-Tropic HIV Type 1 Is Associated with a Majority Population of CXCR4-Tropic HIV Type 1 in Blood and Declining CD4(+) Cell Counts.
- Oral sampling and human papillomavirus genotyping in HIV-infected patients.
- Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.
- CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
- HIV-1 RNA Rectal Shedding Is Reduced in Men With Low Plasma HIV-1 RNA Viral Loads and Is Not Enhanced by Sexually Transmitted Bacterial Infections of the Rectum.
- Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure.
- High Prevalence of Persistent Parasitic Infections in Foreign-Born, HIV-Infected Persons in the United States.
- Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.
- Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during th...
- Antiretroviral therapy: when to start and which drugs to use.
- Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virus.
- Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
- Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.
- A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis.
- Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with ...
- Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of...
- Imported malaria at an inner-city hospital in the United States.
- Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
- Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.
- Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy.
- Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991--2000.
- Anti-Retroviral Therapy Is Associated with Decreased Alveolar Glutathione Levels Even in Healthy HIV-Infected Individuals.
- Quinidine and malaria.
- Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.
- Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
- Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population.
- A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral rep...
- Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.
- Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection.
- Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration.
- Risk of Cryptosporidium parvum transmission between hospital roommates.
- Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.
- The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
- Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.
- Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.
- Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients.
- Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
- Benign symmetric lipomatosis associated with protease inhibitors.
- Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients.
- HIV antibody screening in a general hospital population.
- Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection.
- Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.
- Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-i...
- HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health.
- Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions.
- A retrospective analysis of diseases associated with indeterminate HIV western blot patterns.
- Generalized chronic dermatophytosis in patients with human immunodeficiency virus type I infection and CD4 depletion.
- Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.
- Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy.
- A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group...
- Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.
- Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
- Raltegravir with optimized background therapy for resistant HIV-1 infection.
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind rando...
- Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.
- Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women.
- Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria: a cohort study.
- Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 re...
- Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week ...
Schools
UNIVERSITY OF COLORADO AT DENVER
Walter Reed Army Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Colorado Denver School of Medicine
Hospital
-
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1548376254 | |
| NPPES Provider LastName | LENNOX | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 303082012 | |
| NPPES Provider State | GA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 904.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548376254 |
| Last Name Of The Provider | LENNOX |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Bruce S. Ribner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nadine G. Rouphael, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minh T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Margaret Williamson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott K. Fridkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen F. Dunne, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles D. Wells, MD |